Autres langues Kaneka Corporation

Actions

4118

JP3215800008

Marché Fermé - Japan Exchange Autres places de cotation 08:00:00 15/05/2024			Varia. 5j.	Varia. 1 janv.
4 059 ^JPY	-1,70 %		-0,90 %	+13,32 %

22/04	Sony Corporation adopte le produit moulé en mousse de Kaneka Corporation fabriqué à partir du polymère biodégradable Green Planet de Kaneka comme matériau de rembourrage pour ses téléviseurs à grand écran.	CI
08/02	Kaneka Corporation (TSE:4118) annonce un rachat d'actions pour 2.000.000 d'actions, représentant 3,08%, pour un montant de 8.000 millions ¥.	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Schaumstoffformteil aus biologisch abbaubarem KANEKA-Polymer Green PlanetTM wird als Polstermaterial für Großbildfernseher von Sony verwendet	22/04
Foam Molded Product made from KANEKA Biodegradable Polymer Green PlanetTM Adopted for Sony’s Large-screen TV Cushioning Material	22/04
Sony Corporation Adopts Kaneka Corporation's Foam Molded Product Made from Kaneka Biodegradable Polymer Green Planet as A Cushioning Material for Its Large-Screen Televisions	22/04
Sony is the Industry's First to Eliminate Polystyrene Foam Packaging for Large TVs	18/04
Tranche Update on Kaneka Corporation's Equity Buyback Plan announced on February 8, 2024.	01/04
Kaneka Corporation announces an Equity Buyback for 2,000,000 shares, representing 3.08% for ¥8,000 million.	08/02
Kaneka Corporation authorizes a Buyback Plan.	08/02
Kaneka erwirbt Japan Medical Device Technology	06/12
Kaneka Acquires Japan Medical Device Technology	06/12
Kaneka Corporation acquired Japan Medical Device Technology Co., Ltd.	30/11
Kaneka : Acquires Japan Medical Device Technology	30/11
Kaneka : Quarterly Financial Results for the 2nd Quarter, Ended September 30, 2023	14/11
Kaneka : initiates Clinical Trial for Acute Spinal Cord Injury using Human (Allogeneic) Amnion-derived Mesenchymal Stem Cells	30/08/23
Kaneka : Quarterly Financial Results for the 1st Quarter, Ended June 30, 2023	18/08/23
Kaneka : Quarterly Financial Summary for the 1st Quarter, Ended June 30, 2023	18/08/23
Kaneka : initiates Clinical Trial for Duchenne Muscular Dystrophy using Human (Allogeneic) Amnion-derived Mesenchymal Stem Cells	28/07/23
Kaneka : Data Sheet 2022	21/07/23
Kaneka : Financial Summary for the Fiscal Year Ended March 31, 2023	23/05/23
Sun-Novo Pharma Gets License to Produce Kaneka’s Transdermal Patches	16/05/23
Kaneka Corporation Reports Earnings Results for the Full Year Ended March 31, 2023	12/05/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Kaneka Corporation

Actions

4118

JP3215800008

Autres langues

Filtres